The global disposable medical nonwovens market will reach US $20 billion in 2017. At present, the 5 most developed markets in the world are the United States, Europe (mainly EU countries), Canada, Japan and Australia, which account for about 90% of the world's total sales. The developed countries have invested heavily in the research and development of multi-storey warp knitted artificial blood vessels, warp knitted textile heart valves, hollow fiber artificial kidney and high-end medical accessories, with a large number of specialized research institutes and enterprises, and a perfect technology and production system has been formed.

However, at present, the medical and health textiles in China are mainly concentrated in the medical protection and health care products with low technical content, while surgical suture lines, artificial blood vessels, artificial dialysis catheters, artificial skin and other implanted and artificial organ products have been in the basic research stage due to backward technology and industry barriers.

China is the world's largest producer of non implanting textiles and health care textiles for surgery. In 2014, the output of the medical and textile industry reached 1 million 188 thousand tons. However, at present, the proportion of disposable protective textiles used by medical institutions in China is less than 5%, which will cause a large number of postoperative infections, cross infection and repeated infection each year. Increasing the development and industrialization of disposable textile materials for medical and health care can not only greatly improve the level of medical protection in China, but also save a lot of medical resources.

In general, biodegradable, composite, functional, minimally invasive and intelligent are the development directions of medical textile technology products in the world, including the design and synthesis of new generation biomaterials, nano biomaterials and soft nanotechnology. manufacturing technology The technology of textile processing technology, such as material composite technology, tissue engineering technology, artificial organ, and so on, has become a technological support for the development of medical textile technology products.

To ensure the healthy development of medical textile materials, we should focus on three aspects. First, strengthen disposable medical treatment. textile In order to meet the requirements of the medical market development by antibacterial technology and other surface active technologies, we should solve the new requirements of future surgical non-invasive surgery, point disinfection application, wound sterilization before disinfection, and so on.

Two, we should speed up the improvement. Industrial convergence We should promote market mechanism, build industrial technology collaborative innovation chain, support industries to occupy high-end value chain, and achieve win-win situation. To gain more market attention, medical textiles need close cooperation between manufacturers and medical departments. Especially in the initial stage of new product design and development, hospitals should familiarise themselves with medical textiles as soon as possible, clarify the benefits of these innovative products, and further reduce the cost of medical textiles with the help of technological progress and economies of scale, and break through the market of traditional textile materials.

The three is to establish a complete and perfect industrial development policy. We should strengthen basic research and interdisciplinary exchanges, set up major projects for high-end medical textiles, develop basic research and new product development from fiber materials, processing technology to medical engineering, strengthen inter departmental coordination, set up inter departmental coordination and promotion mechanisms and Industrial Technology Innovation Alliances in terms of product standards, use standards, R & D and production applications, establish quality assurance systems, formulate different grading indicators and use suggestions, guide enterprises to carry out R & D and production in accordance with corresponding standards, promote virtuous circle, strengthen access management, strengthen qualification authentication and quality supervision in circulation links, circulate institutions to carry out necessary testing and production supervision for products, improve physical and capacity reserve systems, and establish reserve rotation mechanism to meet the normal market supply and deal with unexpected needs.